Navigation Links
Champion hydrogen-producing microbe
Date:12/14/2010

oxygen, respiration creates the oxygen-free or anoxic conditions inside the bacteria the nitrogenase needs to do its work.

Cyanothece's clock is set by the environmental cue of changing light levels. But once entrained by the day/night cycle, the clock continues to run even in the absence of the cues. Just as a prisoner kept in solitary confinement will maintain a roughly 24-hour sleep/wake cycle, Cyanothece will continue to fix nitrogen even if it is incubated under continuous light.

As Pakrasi puts it, the entrained microbes are still experiencing "subjective dark" for 12 hours of the day.

More strangely, entrained Cyanothece incubated under continuous light evolve more hydrogen than those cycling between light and dark. This is probably because the energy in light somehow fuels the energy-intensive nitrogenase reaction, says Anindita Bandyopadhyay, PhD, a postdoctoral fellow in Pakrasi's lab. The scientists are still trying to understand exactly why this happens.

In addition to keeping the microbes awake all night, the scientists have another trick up their lab coat sleeves. Cyanothece can survive on the starvation diet of sunlight and air but adaptable microbe that it is, it can also live on carbon-containing molecules or on a mix of sunlight and carbon-containing molecules.

The scientists found that the microbes produced more hydrogen if they were grown in cultures that contained glycerol, a colorless, sweet-tasting molecule that is frequently used as a food additive.

The additional carbon in the glycerol revs up the nitrogenase to meet the increased demand for nitrogen in the cells, Pakrasi says. And the more active the nitrogenase, the more hydrogen is produced.

Despite journalistic hype, Pakrasi warns, hydrogen is not the fuel of tomorrow. It's hard to transport and its energy density is too low. The fuel tank for a semi-trailer powered by hydrogen would take up half
'/>"/>

Contact: Diana Lutz
dlutz@wustl.edu
314-935-5272
Washington University in St. Louis
Source:Eurekalert  

Page: 1 2 3 4

Related biology technology :

1. Champions Biotechnology Reports Additions to its Management Team
2. Orthopedics Entrepreneur Named BioCrossroads Watanabe Life Sciences Champion of the Year
3. Champions Biotechnology Reports Fiscal 2011 First Quarter Financial Results
4. Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results
5. Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology
6. Champions Biotechnology to Present Data at AACR-EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft(TM) Platform to Guide Personalized Cancer Treatment and Accelerate Oncology Drug Development
7. Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts(TM)
8. Champions Biotechnology Reports Fiscal 2010 First Quarter Financial Results
9. Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement
10. Champions Biotechnology to Present at Rodman & Renshaws Eleventh Annual Healthcare Conference
11. Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Champion hydrogen-producing microbe
(Date:9/30/2014)... Follow us on LinkedIn –Cholesterol ... cholesterol carrier or lipoprotein in the blood. Such tests ... in the body, especially along the walls of blood ... other cardiovascular disorders. Cardiovascular Diseases (CVD) is the leading ... on a regular basis, to assess an individual’s risk ...
(Date:9/30/2014)... 2014 CORD:USE Cord Blood Bank – ... has entered into an Equity and Exclusive Services Agreement ... series of patented technologies for the isolation of human ... Tianhe is performing Phase I/II clinical trials in ... using Tianhe,s Stem Cell Educator Therapy showing that ...
(Date:9/30/2014)... 30, 2014 Genedata, a ... drug discovery and related life science research, ... chosen Genedata Selector as its host-pathogen data ... FUNGITECT is a European consortium dedicated to ... via individualized anti-fungal drug therapies. Genedata Selector ...
(Date:9/30/2014)... 30, 2014  KemPharm, Inc., a clinical-stage specialty ... of proprietary new molecular entity (NME) prodrugs, announced ... Office (USPTO) issued U.S. Patent No. 8,816,083 to ... Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates ... Thereof." The patent, which extends through ...
Breaking Biology Technology:Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 2Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 3Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 4CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 2CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 3CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 4FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2
... , ST. LOUIS, Aug. 7 KV Pharmaceutical Company ... owners of the Company,s Class A and Class B Common Stock, ... by written consent purported to have been taken by such Reporting ... of the Company,s By-Laws and is therefore invalid and not effective. ...
... , , BOTHELL, Wash., Aug. ... today reported financial results for the three and six months ended ... Bruce Morra, SCOLR Pharma,s President and CEO, said, "We continue to ... controlled release ibuprofen. These potential partners have been committing resources to ...
... , , , , ... 2Q09 Corporate Highlights: , , ... treatment of peripheral neuropathic pain in non-diabetic adults, either alone or in combination ... agreement with Astellas Pharma Europe Ltd. (Astellas) for commercialization of Qutenza in Europe, ...
Cached Biology Technology:KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid 2KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid 3KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid 4KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid 5KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid 6SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 8NeurogesX Reports Second Quarter 2009 Results 2NeurogesX Reports Second Quarter 2009 Results 3NeurogesX Reports Second Quarter 2009 Results 4NeurogesX Reports Second Quarter 2009 Results 5NeurogesX Reports Second Quarter 2009 Results 6NeurogesX Reports Second Quarter 2009 Results 7NeurogesX Reports Second Quarter 2009 Results 8NeurogesX Reports Second Quarter 2009 Results 9NeurogesX Reports Second Quarter 2009 Results 10NeurogesX Reports Second Quarter 2009 Results 11NeurogesX Reports Second Quarter 2009 Results 12
(Date:9/30/2014)... to know what goes wrong with your muscles because of ... what "normal" actually is. That,s where a new research report ... FASEB Journal comes in. In the report, a ... molecules that can help scientists "see" which genes are active ... found never-before-detected gene activity and that men have approximately 400 ...
(Date:9/30/2014)... Sept. 30, 2014  Spectra Automation, a ... the biotech and power generation industries, announced ... Bioprocess Manager, an easy-to-use and cost-effective data ... bioprocess development laboratories. Most ... and analyzer systems. Accessing and consolidating data ...
(Date:9/30/2014)... Winners of The Economist,s prestigious Innovation awards 2014 will ... at the JW Marriott Hong Kong on Friday, October 10 th ... experiences and the lessons those hold for others. The awards, which ... past decade, will be presented at a ceremony in ... be the first time the ceremony has come to ...
Breaking Biology News(10 mins):Scientists identify which genes are active in muscles of men and women 2Spectra Automation Introduces RECONN Bioprocess Manager 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7
... try savoring the scent of lemon, mango, lavender, or ... first scientific evidence that inhaling certain fragrances alter gene ... stress levels. Their study appears in ACS, Journal ... In the new study, Akio Nakamura and colleagues ...
... Applying biological molecules from cell membranes to ... on the very basics of cell-to-cell interaction. ... Oregon biophysicist and colleagues suggest that putting lipids ... could lead to new classes of self-assembling materials ...
... allows farmers to harvest rice earlier, giving them more time ... and ease hunger during monga -- the hunger months. ... from September to November after the previous season,s food has ... December. According to the Bangladesh Bureau of Statistics, ...
Cached Biology News:New windows opened on cell-to-cell interactions 2New windows opened on cell-to-cell interactions 3Early rice harvests ease annual famine in Bangladesh 2
... Lambda Protein Phosphatase ( ... protein phosphatase with activity ... and tyrosine residues. It ... product of the ORF221 ...
Angiotensin Converting Enzyme [Porcine Kidney, ACE, Peptidyl-dipeptidase A]...
Oven mesh sheets, large, 23 x 23cm, pack of 5...
Preparation Note: Prepared essentially by method of Singer, T.P., J. Biol. Chem., 174, 11 (1948). Quality Clarifier: Contains lipase Unit Definition: One unit will hydrolyze 1.0 μmole of p-ni...
Biology Products: